Following up on both bfw's and Bear's posts. I have been thinking for a while that, mediocre business management aside, one of the largest drawbacks to investing in RVX is clarity as to where the line is between the two companies wrt IP ownership. From the outside that line would seem to be in a constant state of flux as more is learned about the MOA of apabetalone. This does not give many investors the certainty they need to make an informed investment decision. I think it is imperative that management clarify this. To me the best way to provide clarity would be to effect the split of Zenith into op co (ZEL) and Zenith Capital Corporation and then merge ZEL and RVX so that all the IP is held in a single investable corporation. This would immediately provide the following; IP clarity which is needed, liquidity for long suffering Zenith shareholders, ensure that the RVX preferred shares are isolated from further dilution and perhaps provide enough combined enterprise value to take the new RVX to a NASDAQ listing. I think many investors would view the combined company as far more investable due to clarity as well as the fact that the investment would have a greater number of opportunities to achieve success. JMO